We create, populate, and provide unblinding communications to trial sites for distribution to participants.
A CISCRP survey showed that patients were interested in receiving a summary of their individual trial results (64%) and knowing if they had been given a placebo (52%)1.
of participants want to know their individual trial results
Fulfill another critically unmet ethical imperative by letting each trial participant know of their treatment assignment(s) once the trial is completed.
Develop a study-specific template or a globally applicable standardized approach that enables study teams to easily implement this communication and build trust with your patient population.
Unblinding Communications provide trial participants with:
Dominantly Inherited Alzheimer’s Disease Brochure
Expanded Registry Flyer (English)
Enfermedad de Alzheimer de herencia dominante
Expanded Registry Flyer (Spanish)
Forgetting the Little Things
Concerned About Memory Loss?
Click on the resources listed below to view the full versions of LCI’s materials.